Compound Detail
CHEMBL1760591
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1760591 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DBIKJXXBCAHHMC-WOJBJXKFSA-N |
3
Targets
4
Activities
1
Assay Types
0
PK Parameters
10
Publications
0
Known Names
Molecular Properties
378.4
MW (Da)
1.81
ALogP
7
HBA
4
HBD
108.6
PSA (Ų)
0.50
QED
0
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 4.58
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| XF498 | IC50 | = | 26560.0 | nM | 4.58 | Anticancer activity against human XF498 cells by SRB assay | 21420296 |
| BV-2 | IC50 | = | 52000.0 | nM | 4.28 | Anti-neuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS... | 21936523 |
| BV-2 | IC50 | = | 58490.0 | nM | 4.23 | Antiinflammatory activity in mouse BV2 cells assessed as inhibition of lipopolys... | 21420296 |
| RAW264.7 | IC50 | = | 63400.0 | nM | 4.2 | Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells preinc... | 21435874 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21936523 | 10.1021/np200541m | BV-2 | 2 |
| 21420296 | 10.1016/j.bmcl.2011.02.104 | BV-2 | 1 |
| 21420296 | 10.1016/j.bmcl.2011.02.104 | A549 | 1 |
| 21420296 | 10.1016/j.bmcl.2011.02.104 | SK-MEL-2 | 1 |
| 21420296 | 10.1016/j.bmcl.2011.02.104 | XF498 | 1 |
| 21420296 | 10.1016/j.bmcl.2011.02.104 | SK-OV-3 | 1 |
| 21435874 | 10.1016/j.bmcl.2011.02.102 | RAW264.7 | 1 |
| 21936523 | 10.1021/np200541m | A549 | 1 |
| 21936523 | 10.1021/np200541m | SK-OV-3 | 1 |
| 21936523 | 10.1021/np200541m | SK-MEL-2 | 1 |
Data from ChEMBL 36 via Core Engine